Direct tumour injection of immunotherapy activates the immune system, shrinks cancers, and may prevent spread with fewer side effects.
Vous n'êtes pas connecté
Maroc - ONCOLOGYNEWS.COM.AU - A La Une - 05/11/2024 16:02
Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a pivotal role in anti-tumour immunity. The pre-clinical findings, published in Nature, highlight the potential to activate these cells to fight tumours more effectively, offering new hope for broader treatment success, particularly [...]
Direct tumour injection of immunotherapy activates the immune system, shrinks cancers, and may prevent spread with fewer side effects.
Direct tumour injection of immunotherapy activates the immune system, shrinks cancers, and may prevent spread with fewer side effects.
Highlights: Direct tumour injection activates a whole-body immune attack Early trials show tumour shrinkage and
iNKT therapy, agenT-797, delivers context-dependent immune reprogramming showing activation in cancer and anti-inflammatory benefit in ARDS — from...
Scientists say stem cell transplantation is often the only potential cure for some highly aggressive types of blood cancer such as leukemia. ......
Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it is properly activated. In...
Although cancer immunotherapy has transformed treatment by harnessing the immune system to eliminate tumors, only a small subset of patients benefit....
BriaCell Therapeutics (NASDAQ:BCTX) got FDA approval for clinical trials of a new off-the-shelf immunotherapy for metastatic breast cancer.
BriaCell Therapeutics (NASDAQ:BCTX) got FDA approval for clinical trials of a new off-the-shelf immunotherapy for metastatic breast cancer.
A NEW one-minute cancer drug injection will speed up treatment for thousands of NHS patients. The medicine pembrolizumab, aka Keytruda, will be...